NEW YORK (GenomeWeb News) – As part of a new push to ramp up the UK's synthetic biology business sector, the UK government plans to provide £10 million ($16 million) over five years to fund the creation of a center that will accelerate development of new synthetic biology technologies toward commercialization.

The Biotechnology and Biological Sciences Research Council (BBSRC) said today that it wants proposals from institutions interested in founding an Innovation and Knowledge Centre (IKC) in Synthetic Biology that will support and develop new businesses in this industry.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.